For the Inventor, By the Inventor

Enter assignee name

Andover, MA, United States of America

Embecta Corp.

USPTO Granted Patents = 37

CIPO Patents = 2

EPO Patents = 15

Trademarks = 7

Forward Citations = 39

Loading Chart...

Loading Chart...

81 inventors (with patents filed for the assignee):

Amit Uday Limaye (7 out of 52 patents)

Sudarsan Srinivasan (6 out of 35 patents)

Sean Sullivan (4 out of 21 patents)

4. Christopher Rini (3 out of 10 patents)

5. Richard Klug (3 out of 15 patents)

6. Bruce Clyde Roberts (3 out of 9 patents)

7. Ronald J Pettis (3 out of 50 patents)

8. Robert Banik (3 out of 53 patents)

9. Edward Liebowitz (3 out of 7 patents)

10. Xi Zeng (3 out of 5 patents)

11. Huasheng Huang (3 out of 5 patents)

12. Didier Morel (3 out of 4 patents)

13. David E Huang (3 out of 57 patents)

14. Robert E West (3 out of 30 patents)

15. Peter Aziz Girgis (3 out of 3 patents)

Core Competencies:

Pen Needle

Infusion Delivery

Integrated Disease Management

Graphical User Interface

Injection Site Rotation

Safety Mechanisms

Medication Delivery

Analyte Concentration

Calibration Systems

Cloud Connectivity

Packaging Solutions

Needle Storage

37 patents: Sort by Forward Citations

1. 12582764 - Pen needle magazine (2026-03-24),

2. 12370324 - Pen needle (2025-07-29),

3. 12296156 - Pen needle with retractable shield (2025-05-13),

4. 12257423 - Pen needle (2025-03-25),

5. D1052600 - Display screen or portion thereof with a graphical user interface for an integrated disease management system (2024-11-26),

6. 12121699 - Systems and methods for monitoring operations of an infusion delivery device using a pressure sensor (2024-10-22),

7. 12046370 - Integrated disease management system (2024-07-23),

8. 12023474 - Pen needle hub injection depth optimization (2024-07-02),

9. D1032641 - Display screen or portion thereof with a graphical user interface for an integrated disease management system (2024-06-25),

10. D1003307 - Display screen or portion thereof with a graphical user interface for an integrated disease management system (2023-10-31),

11. 11766526 - Systems, apparatuses and methods to encourage injection site rotation and prevent lipodystrophy from repeated injections to a body area (2023-09-26),

12. 11744957 - Pen needle assembly apparatus (2023-09-05),

13. 11717604 - Pen needle storage (2023-08-08),

14. 11684727 - Pen needle apparatus (2023-06-27),

15. 11679208 - Systems, apparatuses and methods to encourage injection site rotation and prevent lipodystrophy from repeated injections to a body area (2023-06-20),

Embecta Corp. is a leading global provider of diabetes management solutions, specializing in the development and manufacturing of insulin delivery devices. The company focuses on enhancing the quality of life for individuals with diabetes through innovative technologies and products. With a commitment to research and development, Embecta aims to advance diabetes care by providing reliable and user-friendly devices that cater to the needs of patients worldwide. Headquartered in Andover, Massachusetts, Embecta plays a significant role in the healthcare landscape.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

37 Patents

#9 in Andover, MA

#537 in Massachusetts

#9,241 in US

#18,238 in the World

Andover, MA, United States of America

Embecta Corp.

Forward Citations = 39

81 inventors:

Amit Uday Limaye (7 out of 52 patents)

Sudarsan Srinivasan (6 out of 35 patents)

Sean Sullivan (4 out of 21 patents)

4. Christopher Rini (3 out of 10 patents)

5. Richard Klug (3 out of 15 patents)

Please report any incorrect information to [email protected]

Loading…